The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Photosensitivity reaction 2
SANDOSTATIN LAR DEPOT Pituitary tumour recurrent 2
SANDOSTATIN LAR DEPOT Pituitary-dependent Cushing's syndrome 2
SANDOSTATIN LAR DEPOT Pleuritic pain 2
SANDOSTATIN LAR DEPOT Post procedural pneumonia 2
SANDOSTATIN LAR DEPOT Postmenopausal haemorrhage 2
SANDOSTATIN LAR DEPOT Posture abnormal 2
SANDOSTATIN LAR DEPOT Product deposit 2
SANDOSTATIN LAR DEPOT Prostatic specific antigen increased 2
SANDOSTATIN LAR DEPOT Psychiatric symptom 2
SANDOSTATIN LAR DEPOT Pterygium 2
SANDOSTATIN LAR DEPOT Pulmonary hypertension 2
SANDOSTATIN LAR DEPOT Respiratory arrest 2
SANDOSTATIN LAR DEPOT Respiratory failure 2
SANDOSTATIN LAR DEPOT Retching 2
SANDOSTATIN LAR DEPOT Retinal tear 2
SANDOSTATIN LAR DEPOT Rhonchi 2
SANDOSTATIN LAR DEPOT Rosacea 2
SANDOSTATIN LAR DEPOT Salmonellosis 2
SANDOSTATIN LAR DEPOT Scleroderma 2

Total Records: 2,045     Number of Pages: 103